Show simple item record

dc.contributor.authorWakeham, Joseph
dc.contributor.authorShaw, Philippa A.
dc.contributor.authorDutton, Brittany
dc.contributor.authorWildman, Levine
dc.date.accessioned2017-10-16T08:21:40Z
dc.date.available2017-10-16T08:21:40Z
dc.date.issued2017
dc.identifier.citationCardoso, D., Wakeham, J., Shaw, P. A., Dutton, B. & Wildman, L. (2017). Chlorpromazine versus thiothixene for people with schizophrenia. Cochrane Database of Systematic Reviews, (9), 1-19.en
dc.identifier.other10.1002/14651858.CD012790
dc.identifier.urihttp://hdl.handle.net/20.500.12904/9761
dc.description.abstractThis is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To review the effects of chlorpromazine compared with thiothixene for people with schizophrenia. © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.en
dc.description.urihttp://onlinelibrary.wiley.com/doi/10.1002/14651858.CD012790/full
dc.formatFull text uploaded
dc.subjectSchizophreniaen
dc.subjectDrug therapyen
dc.titleChlorpromazine versus thiothixene for people with schizophreniaen
dc.typeArticle
refterms.dateFOA2021-06-14T11:07:38Z


Files in this item

Thumbnail
Name:
Cardoso 2017 1-19.pdf
Size:
300.9Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record